Genmab — December 2020

[E_L]

https://twitter.com/juliaskripkaser/status/1335925864127750145/photo/1

[AaBforever]

Jeg refererer kun fra Børsen. Man skal altid have alle aspekter med inden vi kammer helt over;-)

[Doublo]

Hvad sker der i ordredybden for Genmab? selv om der er 4 x så mange der vil købe, så rykkes køb hele tiden ned så der er færre der vil købe til den aktuelle kurs, uanset hvor meget kurset falder, jeg har aldrig set det før?? det ligner manipulation!

[deleted-user]

Så stoppede den leg

[deleted-user]

Det var så kun for 30 sek., så overtog algo'en...

[nohope]

Regn med kursen stiger - jeg har nemlig lige solgt....

[Doublo]

Ja og telefonen ringede så jeg fik lige akkurat IKKE solgt!

[E_L]

ASH 2020 Highlights – Diffuse Large B Cell Lymphoma (DLBCL) https://prescienthg.com/resources/2020/12/04/ash-2020-diffuse-large-b-cell-lymphoma-dlbcl/ (can also click on
MM)

[nohope]

Jeg understøtter kursen på GEN ved at sælge, det er undtagelsesfrit, at den stiger, når jeg sælger.

[E_L]

New Dara trial https://clinicaltrials.gov/ct2/show/NCT04656951?term=NCT04656951&draw=2&rank=1

[Doublo]

Pensionisten du må undskylde hvis vi har overtrådt nogen regler?

[JohnW]

Så sælg lidt flere @nohope

[E_L]

New DARZALEX (daratumumab) Data from GRIFFIN Study Show Deeper and Longer Responses in Patients with Newly Diagnosed Multiple Myeloma https://www.prnewswire.com/news-releases/new-darzalex-daratumumab-data-from-griffin-study-show-deeper-and-longer-responses-in-patients-with-newly-diagnosed-multiple-myeloma-301187387.html

[E_L]

Data from the ANDROMEDA Study Show Hematologic Response for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) in Newly Diagnosed Light Chain (AL) Amyloidosis https://www.prnewswire.com/news-releases/data-from-the-andromeda-study-show-hematologic-response-for-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-in-newly-diagnosed-light-chain-al-amyloidosis-301187390.html

[Helge_LarsenPI-redaktør]

Ritzau: https://www.proinvestor.com/investornyt/670148/genmab-sydbank-saerdeles-positive-data-fra-nyt-studie

[E_L]

FiercePharma -ASH: Johnson & Johnson shores up Darzalex's myeloma lead with another subcutaneous win https://www.fiercepharma.com/pharma/ash-johnson-johnson-shores-up-darzalex-s-myeloma-lead-another-subcutaneous-win

[E_L]

Griffin , looking at the patients from the safety run-in phase, after 24 months 94%sCR....

[E_L]

Dr Mark Wildgust: GRIFFIN Findings Show Adding Daratumumab to Induction, Maintenance Regimens Improves Rate, Depth of Response https://www.ajmc.com/view/dr-mark-wildgust-griffin-findings-show-adding-daratumumab-to-induction-maintenance-regimens-improves-rate-depth-of-response

[Helge_LarsenPI-redaktør]

Bloomberg Markets @markets
Biotech stocks rallied to a record Monday in reaction to a deluge of data on blood disease treatments presented at the American Society of Hematology https://trib.al/dm8Ce0l

[Klarussen]

De glemte at nævne Genmab…